GENE ONLINE|News &
Opinion
Blog

Phase 3 Trial
Trials & Approvals ChikungunyaVaccine
Bavarian Nordic Closes on Valneva in Chikungunya Vaccine Race
2023-08-14
Asia-Pacific AnxietyPhase 3 Trial
Vistagen’s Positive Phase 3 Results for Social Anxiety Treatment
2023-08-10
Trials & Approvals Breast Cancer
Novartis’ CDK4/6 Inhibitor Meets Phase 3 Endpoints In Breast Cancer
2023-03-28
Trials & Approvals Rare Disease
AstraZeneca’s Treatment for Rare Throat Disease, Eosinophilic esophagitis, Fails Primary Endpoint
2022-10-25
Trials & Approvals HIV
Merck’s Phase 2 HIV Treatment Study Resumes with Phase 3 Program Announcement
2022-09-20
Trials & Approvals Plaque Psoriasis
Study for Janssen Pharmaceuticals’ Severe Plaque Psoriasis Treatment Provides Optimization Insight
2022-09-08
IPO Asia
Belite Bio Clears Biopharma IPO Drought, with HilleVax and Tenon Medical Close Behind
2022-05-03
Trials & Approvals FDA Approval
BioXcel Gets FDA Nod for First Oral Sublingual Film for Schizophrenia Treatment
2022-04-08
China Autoimmune
GSK’s Benlysta Bags Approval for Lupus Nephritis Treatment in China
2022-02-14
Regulatory FDA
Applied Therapeutics’ Galactosemia Program Stumbles Again after FDA Requests for More Data
2022-01-04
Trials & Approvals Heart Failure
Eli Lilly and Boehringer Ingelheim’s Jardiance Shows Encouraging Phase 3 HFpEF Data
2021-07-07
Trials & Approvals
FDA Rejection of Type 1 Diabetes Drug Impacts Provention Bio’s Stocks
2021-07-07
Trials & Approvals JAK1 Inhibitor
AbbVie’s JAK1 Inhibitor Aces Ulcerative Colitis Trial, Prospers Amid Tough Regulatory Climate
2021-07-02
COVID-19 Vaccine
Novavax to Seek Regulatory Approval After COVID-19 Vaccine Displays 90% Efficacy in US Trial
2021-06-15
Cancer
Samsung Biologics Renews Manufacturing Deal to Expand Production of TG Therapeutics’ Cancer Drug
2021-04-27
1 2 3 … 6
LATEST
Breakthrough Screening Platform to Assess SARS-CoV-2 Mutations and Potential Treatments
2024-04-16
Join Us for the SABPA OC/LA 16th Annual Biomedical Forum!
2024-04-16
Sequencing Revolution Spotlights the Titans of NGS Innovation
2024-04-16
Oncology’s New Drugs on the Horizon (II): Radiotherapy, Radioligands & Other Therapeutic Agents
2024-04-12
Oncology’s New Drugs on the Horizon (I): Cancer Immunotherapy and Targeted Therapy
2024-04-12
Vertex Pharmaceuticals Makes $4.9 Billion Bet on Kidney Disease Treatment through Alpine Immune Acquisition
2024-04-11
Bayer Signs New Partnership with Google Cloud, Joining Hands for AI Solutions for Radiologists
2024-04-10
READ MORE
EVENT
2024-04-20
16th SABPA OC/LA Annual Biomedical Forum
The Beckman Center, 100 Academy, Irvine, CA, 92617
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top